Could a 5-Minute nasal light zap stop surgical infections?
NCT ID NCT07189858
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested a device that uses light to kill germs in the nose before surgery, aiming to prevent surgical site infections. Over 400 adults having major surgeries received either the light treatment or standard care. Researchers tracked infections and side effects for 30 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nasal antimicrobial photodisinfection therapy (Steriwave device)
- What this could lead to
- If effective, this could offer a quick, drug-free way to lower the chance of infections after surgery.
- What could go wrong
- The trial is completed but results are not yet widely confirmed. The effect may vary by surgery type, and the device is not a substitute for standard hygiene measures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-INFECTIVE AGENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Foothills Medical Centre
Calgary, Alberta, T2N 2T9, Canada
-
Rockyview General Hospital
Calgary, Alberta, T2V 1P9, Canada
-
Royal Columbian Hospital
New Westminster, British Columbia, V3L 0A2, Canada
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2X8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
- Experimental malaria vaccine aims to block parasite growth
- Rare disease drug shows promise in reducing infections
- New rapid test for infection and inflammation put to the test
- Placenta cells tested as COVID fighter – but trial stopped early
- Fast new swab test could speed up vaginitis diagnosis